Beam Therapeutics Inc (BEAM)
26.40 x 1 29.00 x 1
Post-market by (Cboe BZX)
28.48 +1.23 (+4.51%) 03/07/25 [NASDAQ]
26.40 x 1 29.00 x 1
Post-market 28.49 +0.01 (+0.04%) 19:15 ET
for Fri, Mar 7th, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 281,967 | 230,203 | 292,763 | 287,848 | 435,895 |
Marketable Securities | 568,773 | 695,554 | 715,402 | 806,706 | 753,981 |
TOTAL | $878,149 | $945,534 | $1,029,440 | $1,121,710 | $1,211,043 |
Non-Current Assets | |||||
PPE Net | 111,412 | 113,502 | 117,470 | 120,922 | 124,960 |
Other Non-Current Assets | 114,263 | 112,331 | 114,356 | 117,164 | 123,711 |
TOTAL | $225,675 | $225,833 | $231,826 | $238,086 | $248,671 |
Total Assets | $1,103,824 | $1,171,367 | $1,261,266 | $1,359,796 | $1,459,714 |
Liabilities | |||||
Current Liabilities | |||||
Accounts payable and accrued liabilities | 3,871 | 3,812 | 4,429 | 2,790 | 1,617 |
Accrued Expenses | 47,468 | 51,769 | 67,138 | 86,437 | 111,664 |
Other current liabilities | 8,400 | 8,400 | 8,200 | 13,700 | 10,800 |
TOTAL | $182,066 | $166,244 | $177,333 | $187,219 | $205,565 |
Non-Current Liabilities | |||||
Deferred Revenues | 108,858 | 89,327 | 84,925 | 72,111 | 68,706 |
aiOther Non-Current Liabilities | 154,995 | 155,990 | 229,839 | 259,087 | 162,932 |
TOTAL | $188,213 | $213,806 | $229,839 | $259,087 | $272,820 |
Total Liabilities | $370,279 | $380,050 | $407,172 | $446,306 | $478,385 |
Shareholders' Equity | |||||
Shares Outstanding, K | 83,688 | 82,806 | 82,416 | 82,311 | 81,658 |
Common Shares | 836 | 826 | 824 | 823 | 816 |
Retained earnings | -1,566,631 | -1,476,277 | -1,379,609 | -1,288,558 | -1,189,889 |
Other shareholders' equity | 679 | 1,759 | -1,110 | -921 | 604 |
TOTAL | $733,545 | $791,317 | $854,094 | $913,490 | $981,329 |
Total Liabilities And Equity | $1,103,824 | $1,171,367 | $1,261,266 | $1,359,796 | $1,459,714 |